在B型流感的第214位单一突变增强了交叉中和

Ziqi Cheng1,2, Yeqing Sun1,2, Yanru Shen2

  • 1National Engineering Laboratory for AIDS Vaccines, School of Life Sciences, Jilin University, Changchun, People's Republic of China.

PubMed
概括

单一的B型流感病毒血蛋白突变大大提高了疫苗交叉中和. 这一发现有助于通过向关键的抗原表位来开发广泛的流感疫苗.